Skip to content
Hodgkin Lymphoma — Statistics · CancerIndex
Population statistics describe groups defined by geography, period and sex. They do not predict any individual outcome. Values labelled "estimated" or "projected" are model outputs from the source, not registry counts.
United States
Incidence rate (age-standardized) Unit: per 100,000 · standard population: 2000 U.S. standard population (19 age groups)
Incidence rate (age-standardized) in United States by year 0 0.9 1.8 2.8 3.7 1999 2002 2006 2009 2013 2016 2020 2023 All · cdc-uscs — 1999: 2.8 All · cdc-uscs — 2000: 2.8 All · cdc-uscs — 2001: 2.8 All · cdc-uscs — 2002: 2.9 All · cdc-uscs — 2003: 2.8 All · cdc-uscs — 2004: 2.9 All · cdc-uscs — 2005: 2.9 All · cdc-uscs — 2006: 2.8 All · cdc-uscs — 2007: 2.9 All · cdc-uscs — 2008: 2.9 All · cdc-uscs — 2009: 2.8 All · cdc-uscs — 2010: 2.8 All · cdc-uscs — 2011: 2.8 All · cdc-uscs — 2012: 2.7 All · cdc-uscs — 2013: 2.7 All · cdc-uscs — 2014: 2.7 All · cdc-uscs — 2015: 2.7 All · cdc-uscs — 2016: 2.6 All · cdc-uscs — 2017: 2.6 All · cdc-uscs — 2018: 2.6 All · cdc-uscs — 2019: 2.6 All · cdc-uscs — 2020: 2.5 All · cdc-uscs — 2021: 2.5 All · cdc-uscs — 2022: 2.5 All · cdc-uscs — 2023: 2.5 Female · cdc-uscs — 1999: 2.5 Female · cdc-uscs — 2000: 2.4 Female · cdc-uscs — 2001: 2.5 Female · cdc-uscs — 2002: 2.6 Female · cdc-uscs — 2003: 2.5 Female · cdc-uscs — 2004: 2.6 Female · cdc-uscs — 2005: 2.6 Female · cdc-uscs — 2006: 2.5 Female · cdc-uscs — 2007: 2.5 Female · cdc-uscs — 2008: 2.6 Female · cdc-uscs — 2009: 2.5 Female · cdc-uscs — 2010: 2.5 Female · cdc-uscs — 2011: 2.4 Female · cdc-uscs — 2012: 2.4 Female · cdc-uscs — 2013: 2.3 Female · cdc-uscs — 2014: 2.4 Female · cdc-uscs — 2015: 2.3 Female · cdc-uscs — 2016: 2.4 Female · cdc-uscs — 2017: 2.4 Female · cdc-uscs — 2018: 2.3 Female · cdc-uscs — 2019: 2.3 Male · cdc-uscs — 1999: 3.2 Male · cdc-uscs — 2000: 3.3 Male · cdc-uscs — 2001: 3.1 Male · cdc-uscs — 2002: 3.2 Male · cdc-uscs — 2003: 3.2 Male · cdc-uscs — 2004: 3.2 Male · cdc-uscs — 2005: 3.3 Male · cdc-uscs — 2006: 3.2 Male · cdc-uscs — 2007: 3.3 Male · cdc-uscs — 2008: 3.3 Male · cdc-uscs — 2009: 3.2 Male · cdc-uscs — 2010: 3.2 Male · cdc-uscs — 2011: 3.2 Male · cdc-uscs — 2012: 3 Male · cdc-uscs — 2013: 3 Male · cdc-uscs — 2014: 3.1 Male · cdc-uscs — 2015: 3 Male · cdc-uscs — 2016: 3 Male · cdc-uscs — 2017: 2.9 Male · cdc-uscs — 2018: 2.9 Male · cdc-uscs — 2019: 3 cdc-uscs Provenance Source U.S. Cancer Statistics (USCS) — NPCR/SEER incidence and NVSS mortality Dataset U.S. Cancer Statistics — Data Visualizations tool data tables (BYSITE.TXT) Version USCS 1999-2023 ASCII package, Nov 2025 submission (last-modified Thu, 04 Jun 2026 20:40:00 GMT; sha256 291765c997e5) Retrieved Sep 8, 2026 Layer normalized (units and labels harmonized; values unchanged) Evidence registry License US Government work (public domain); citation requested; statistical reporting and analysis only; no linkage for re-identification Run ING-CDCUSCS-20260908-000001 Open at source Observed 75 observations · observations differ by dataset and year: hover a row badge for its dataset and version. Year Sex Age group Value (per 100,000) 95% CI Type Site definition Source 2023 All All ages 2.5 2.5–2.6 observed USCS "Hodgkin Lymphoma" (ICD-10 C81; ICD-O-3 histology 9650-9667 (nodal and extranodal)) cdc-uscs 2023 Female All ages 2.2 2.1–2.3 observed USCS "Hodgkin Lymphoma" (ICD-10 C81; ICD-O-3 histology 9650-9667 (nodal and extranodal)) cdc-uscs 2023 Male All ages 2.9 2.8–3 observed USCS "Hodgkin Lymphoma" (ICD-10 C81; ICD-O-3 histology 9650-9667 (nodal and extranodal)) cdc-uscs 2022 All All ages 2.5 2.5–2.6 observed USCS "Hodgkin Lymphoma" (ICD-10 C81; ICD-O-3 histology 9650-9667 (nodal and extranodal)) cdc-uscs
Showing the 12 most recent rows of 75; every year is plotted above and available via the API .
Data updated 22 days ago · Source updated USCS 1999-2023 ASCII package, Nov 2025 submission (last-modified Thu, 04 Jun 2026 20:40:00 GMT; sha256 291765c997e5)
United States
Mortality rate (age-standardized) Unit: per 100,000 · standard population: 2000 U.S. standard population (19 age groups)
Mortality rate (age-standardized) in United States by year 0 0.2 0.4 0.6 0.8 1999 2003 2006 2010 2013 2017 2020 2024 United States
New cases Unit: count
New cases in United States by year 0 2,424 4,848 7,272 9,696 1999 2002 2006 2009 2013 2016 2020 2023 All · cdc-uscs — 1999: 7,733 All · cdc-uscs — 2000: 7,953 All · cdc-uscs — 2001: 7,855 All · cdc-uscs — 2002: 8,245 All · cdc-uscs — 2003: 8,240 All · cdc-uscs — 2004: 8,382 All · cdc-uscs — 2005: 8,630 United States
Deaths Unit: count
Deaths in United States by year 0 379 758 1,136 1,515 1999 2003 2006 2010 2013 2017 2020 2024 All · cdc-uscs — 1999: 1,403 All · cdc-uscs — 2000: 1,287 All · cdc-uscs — 2001: 1,323 All · cdc-uscs — 2002: 1,352 All · cdc-uscs — 2003: 1,347 All · cdc-uscs — 2004: 1,276 All · cdc-uscs — 2005: 1,272 United States
Mortality rate (crude) Unit: per 100,000
Mortality rate (crude) in United States by year 0 0.1 0.2 0.3 0.4 2018 2019 2020 2021 2022 2023 2024 All · cdc-wonder — 2018: 0.3 All · cdc-wonder — 2019: 0.3 All · cdc-wonder — 2020: 0.3 All · cdc-wonder — 2021: 0.3 All · cdc-wonder — 2022: 0.3 All · cdc-wonder — 2023: 0.3 All · cdc-wonder — 2024: 0.3 Data updated 21 days ago · Source updated unknown · 369 observations
Female · cdc-uscs — 2020: 2.2 Female · cdc-uscs — 2021: 2.3 Female · cdc-uscs — 2022: 2.3 Female · cdc-uscs — 2023: 2.2 Male · cdc-uscs — 2020: 2.7 Male · cdc-uscs — 2021: 2.8 Male · cdc-uscs — 2022: 2.8 Male · cdc-uscs — 2023: 2.9 2022 Female All ages 2.3 2.2–2.3 observed USCS "Hodgkin Lymphoma" (ICD-10 C81; ICD-O-3 histology 9650-9667 (nodal and extranodal)) cdc-uscs
2022 Male All ages 2.8 2.8–2.9 observed USCS "Hodgkin Lymphoma" (ICD-10 C81; ICD-O-3 histology 9650-9667 (nodal and extranodal)) cdc-uscs
2021 All All ages 2.5 2.5–2.6 observed USCS "Hodgkin Lymphoma" (ICD-10 C81; ICD-O-3 histology 9650-9667 (nodal and extranodal)) cdc-uscs
2021 Female All ages 2.3 2.2–2.3 observed USCS "Hodgkin Lymphoma" (ICD-10 C81; ICD-O-3 histology 9650-9667 (nodal and extranodal)) cdc-uscs
2021 Male All ages 2.8 2.7–2.9 observed USCS "Hodgkin Lymphoma" (ICD-10 C81; ICD-O-3 histology 9650-9667 (nodal and extranodal)) cdc-uscs
2020 All All ages 2.5 2.4–2.5 observed USCS "Hodgkin Lymphoma" (ICD-10 C81; ICD-O-3 histology 9650-9667 (nodal and extranodal)) cdc-uscs
2020 Female All ages 2.2 2.1–2.3 observed USCS "Hodgkin Lymphoma" (ICD-10 C81; ICD-O-3 histology 9650-9667 (nodal and extranodal)) cdc-uscs
2020 Male All ages 2.7 2.7–2.8 observed USCS "Hodgkin Lymphoma" (ICD-10 C81; ICD-O-3 histology 9650-9667 (nodal and extranodal)) cdc-uscs
All · cdc-uscs — 1999: 0.5 All · cdc-uscs — 2000: 0.5 All · cdc-uscs — 2001: 0.5 All · cdc-uscs — 2002: 0.5 All · cdc-uscs — 2003: 0.5 All · cdc-uscs — 2004: 0.4 All · cdc-uscs — 2005: 0.4 All · cdc-uscs — 2006: 0.4 All · cdc-uscs — 2007: 0.4 All · cdc-uscs — 2008: 0.4 All · cdc-uscs — 2009: 0.4 All · cdc-uscs — 2010: 0.4 All · cdc-uscs — 2011: 0.4 All · cdc-uscs — 2012: 0.3 All · cdc-uscs — 2013: 0.3 All · cdc-uscs — 2014: 0.3 All · cdc-uscs — 2015: 0.3 All · cdc-uscs — 2016: 0.3 All · cdc-uscs — 2017: 0.3 All · cdc-uscs — 2018: 0.3 All · cdc-uscs — 2019: 0.2 All · cdc-uscs — 2020: 0.3 All · cdc-uscs — 2021: 0.3 All · cdc-uscs — 2022: 0.3 All · cdc-uscs — 2023: 0.2 All · cdc-uscs — 2024: 0.2 All · cdc-wonder — 2018: 0.3 All · cdc-wonder — 2019: 0.2 All · cdc-wonder — 2020: 0.2 All · cdc-wonder — 2021: 0.2 All · cdc-wonder — 2022: 0.3 All · cdc-wonder — 2023: 0.2 All · cdc-wonder — 2024: 0.2 Female · cdc-uscs — 1999: 0.4 Female · cdc-uscs — 2000: 0.4 Female · cdc-uscs — 2001: 0.4 Female · cdc-uscs — 2002: 0.4 Female · cdc-uscs — 2003: 0.4 Female · cdc-uscs — 2004: 0.3 Female · cdc-uscs — 2005: 0.4 Female · cdc-uscs — 2006: 0.3 Female · cdc-uscs — 2007: 0.3 Female · cdc-uscs — 2008: 0.3 Female · cdc-uscs — 2009: 0.3 Female · cdc-uscs — 2010: 0.3 Female · cdc-uscs — 2011: 0.3 Female · cdc-uscs — 2012: 0.3 Female · cdc-uscs — 2013: 0.2 Female · cdc-uscs — 2014: 0.2 Female · cdc-uscs — 2015: 0.2 Female · cdc-uscs — 2016: 0.2 Female · cdc-uscs — 2017: 0.2 Female · cdc-uscs — 2018: 0.2 Female · cdc-uscs — 2019: 0.2 Female · cdc-uscs — 2020: 0.2 Female · cdc-uscs — 2021: 0.2 Female · cdc-uscs — 2022: 0.2 Female · cdc-uscs — 2023: 0.2 Female · cdc-uscs — 2024: 0.2 Female · cdc-wonder — 2018: 0.2 Female · cdc-wonder — 2019: 0.2 Female · cdc-wonder — 2020: 0.2 Female · cdc-wonder — 2021: 0.2 Female · cdc-wonder — 2022: 0.2 Female · cdc-wonder — 2023: 0.2 Female · cdc-wonder — 2024: 0.2 Male · cdc-uscs — 1999: 0.6 Male · cdc-uscs — 2000: 0.6 Male · cdc-uscs — 2001: 0.6 Male · cdc-uscs — 2002: 0.6 Male · cdc-uscs — 2003: 0.6 Male · cdc-uscs — 2004: 0.5 Male · cdc-uscs — 2005: 0.5 Male · cdc-uscs — 2006: 0.6 Male · cdc-uscs — 2007: 0.5 Male · cdc-uscs — 2008: 0.5 Male · cdc-uscs — 2009: 0.5 Male · cdc-uscs — 2010: 0.5 Male · cdc-uscs — 2011: 0.5 Male · cdc-uscs — 2012: 0.4 Male · cdc-uscs — 2013: 0.4 Male · cdc-uscs — 2014: 0.4 Male · cdc-uscs — 2015: 0.4 Male · cdc-uscs — 2016: 0.4 Male · cdc-uscs — 2017: 0.3 Male · cdc-uscs — 2018: 0.4 Male · cdc-uscs — 2019: 0.3 Male · cdc-uscs — 2020: 0.3 Male · cdc-uscs — 2021: 0.3 Male · cdc-uscs — 2022: 0.4 Male · cdc-uscs — 2023: 0.3 Male · cdc-uscs — 2024: 0.3 Male · cdc-wonder — 2018: 0.4 Male · cdc-wonder — 2019: 0.3 Male · cdc-wonder — 2020: 0.3 Male · cdc-wonder — 2021: 0.3 Male · cdc-wonder — 2022: 0.3 Male · cdc-wonder — 2023: 0.3 Male · cdc-wonder — 2024: 0.3
cdc-uscs Provenance Source U.S. Cancer Statistics (USCS) — NPCR/SEER incidence and NVSS mortality Dataset U.S. Cancer Statistics — Data Visualizations tool data tables (BYSITE.TXT) Version USCS 1999-2023 ASCII package, Nov 2025 submission (last-modified Thu, 04 Jun 2026 20:40:00 GMT; sha256 291765c997e5) Retrieved Sep 8, 2026 Layer normalized (units and labels harmonized; values unchanged) Evidence registry License US Government work (public domain); citation requested; statistical reporting and analysis only; no linkage for re-identification Run ING-CDCUSCS-20260908-000001 Open at source Observed 99 observations from 2 sources · observations differ by dataset and year: hover a row badge for its dataset and version. Year Sex Age group Value (per 100,000) 95% CI Type Site definition Source 2024 All All ages 0.2 0.2–0.2 observed USCS "Hodgkin Lymphoma" (ICD-10 C81; ICD-O-3 histology 9650-9667 (nodal and extranodal)) cdc-uscs 2024 All All ages 0.2 0.2–0.2 observed C81 cdc-wonder 2024 Female All ages 0.2 0.1–0.2 observed USCS "Hodgkin Lymphoma" (ICD-10 C81; ICD-O-3 histology 9650-9667 (nodal and extranodal)) cdc-uscs 2024 Female All ages 0.2 0.1–0.2 observed C81 cdc-wonder 2024 Male All ages 0.3 0.3–0.3 observed USCS "Hodgkin Lymphoma" (ICD-10 C81; ICD-O-3 histology 9650-9667 (nodal and extranodal)) cdc-uscs 2024 Male All ages 0.3 0.3–0.3 observed C81 cdc-wonder 2023 All All ages 0.2 0.2–0.3 observed USCS "Hodgkin Lymphoma" (ICD-10 C81; ICD-O-3 histology 9650-9667 (nodal and extranodal)) cdc-uscs 2023 All All ages 0.2 0.2–0.3 observed C81 cdc-wonder 2023 Female All ages 0.2 0.2–0.2 observed C81 cdc-wonder 2023 Female All ages 0.2 0.2–0.2 observed USCS "Hodgkin Lymphoma" (ICD-10 C81; ICD-O-3 histology 9650-9667 (nodal and extranodal)) cdc-uscs 2023 Male All ages 0.3 0.3–0.4 observed C81 cdc-wonder 2023 Male All ages 0.3 0.3–0.3 observed USCS "Hodgkin Lymphoma" (ICD-10 C81; ICD-O-3 histology 9650-9667 (nodal and extranodal)) cdc-uscs
Showing the 12 most recent rows of 99; every year is plotted above and available via the API .
Data updated 21 days ago · Source updated USCS 1999-2023 ASCII package, Nov 2025 submission (last-modified Thu, 04 Jun 2026 20:40:00 GMT; sha256 291765c997e5)
All · cdc-uscs — 2006: 8,536 All · cdc-uscs — 2007: 8,676 All · cdc-uscs — 2008: 8,978 All · cdc-uscs — 2009: 8,744 All · cdc-uscs — 2010: 8,797 All · cdc-uscs — 2011: 8,765 All · cdc-uscs — 2012: 8,580 All · cdc-uscs — 2013: 8,611 All · cdc-uscs — 2014: 8,927 All · cdc-uscs — 2015: 8,769 All · cdc-uscs — 2016: 8,774 All · cdc-uscs — 2017: 8,819 All · cdc-uscs — 2018: 8,718 All · cdc-uscs — 2019: 8,965 All · cdc-uscs — 2020: 8,417 All · cdc-uscs — 2021: 8,673 All · cdc-uscs — 2022: 8,810 All · cdc-uscs — 2023: 8,858 Female · cdc-uscs — 1999: 3,509 Female · cdc-uscs — 2000: 3,496 Female · cdc-uscs — 2001: 3,579 Female · cdc-uscs — 2002: 3,762 Female · cdc-uscs — 2003: 3,768 Female · cdc-uscs — 2004: 3,864 Female · cdc-uscs — 2005: 3,914 Female · cdc-uscs — 2006: 3,860 Female · cdc-uscs — 2007: 3,887 Female · cdc-uscs — 2008: 4,060 Female · cdc-uscs — 2009: 3,952 Female · cdc-uscs — 2010: 3,912 Female · cdc-uscs — 2011: 3,871 Female · cdc-uscs — 2012: 3,842 Female · cdc-uscs — 2013: 3,823 Female · cdc-uscs — 2014: 3,956 Female · cdc-uscs — 2015: 3,856 Female · cdc-uscs — 2016: 3,937 Female · cdc-uscs — 2017: 3,984 Female · cdc-uscs — 2018: 3,941 Female · cdc-uscs — 2019: 3,979 Female · cdc-uscs — 2020: 3,768 Female · cdc-uscs — 2021: 3,901 Female · cdc-uscs — 2022: 3,931 Female · cdc-uscs — 2023: 3,892 Male · cdc-uscs — 1999: 4,224 Male · cdc-uscs — 2000: 4,457 Male · cdc-uscs — 2001: 4,276 Male · cdc-uscs — 2002: 4,483 Male · cdc-uscs — 2003: 4,472 Male · cdc-uscs — 2004: 4,518 Male · cdc-uscs — 2005: 4,716 Male · cdc-uscs — 2006: 4,676 Male · cdc-uscs — 2007: 4,789 Male · cdc-uscs — 2008: 4,918 Male · cdc-uscs — 2009: 4,792 Male · cdc-uscs — 2010: 4,885 Male · cdc-uscs — 2011: 4,894 Male · cdc-uscs — 2012: 4,738 Male · cdc-uscs — 2013: 4,788 Male · cdc-uscs — 2014: 4,971 Male · cdc-uscs — 2015: 4,913 Male · cdc-uscs — 2016: 4,837 Male · cdc-uscs — 2017: 4,835 Male · cdc-uscs — 2018: 4,777 Male · cdc-uscs — 2019: 4,986 Male · cdc-uscs — 2020: 4,649 Male · cdc-uscs — 2021: 4,772 Male · cdc-uscs — 2022: 4,879 Male · cdc-uscs — 2023: 4,966
cdc-uscs Provenance Source U.S. Cancer Statistics (USCS) — NPCR/SEER incidence and NVSS mortality Dataset U.S. Cancer Statistics — Data Visualizations tool data tables (BYSITE.TXT) Version USCS 1999-2023 ASCII package, Nov 2025 submission (last-modified Thu, 04 Jun 2026 20:40:00 GMT; sha256 291765c997e5) Retrieved Sep 8, 2026 Layer normalized (units and labels harmonized; values unchanged) Evidence registry License US Government work (public domain); citation requested; statistical reporting and analysis only; no linkage for re-identification Run ING-CDCUSCS-20260908-000001 Open at source Observed 75 observations · observations differ by dataset and year: hover a row badge for its dataset and version. Year Sex Age group Value (count) 95% CI Type Site definition Source 2023 All All ages 8,858 — observed USCS "Hodgkin Lymphoma" (ICD-10 C81; ICD-O-3 histology 9650-9667 (nodal and extranodal)) cdc-uscs 2023 Female All ages 3,892 — observed USCS "Hodgkin Lymphoma" (ICD-10 C81; ICD-O-3 histology 9650-9667 (nodal and extranodal)) cdc-uscs 2023 Male All ages 4,966 — observed USCS "Hodgkin Lymphoma" (ICD-10 C81; ICD-O-3 histology 9650-9667 (nodal and extranodal)) cdc-uscs 2022 All All ages 8,810 — observed USCS "Hodgkin Lymphoma" (ICD-10 C81; ICD-O-3 histology 9650-9667 (nodal and extranodal)) cdc-uscs 2022 Female All ages 3,931 — observed USCS "Hodgkin Lymphoma" (ICD-10 C81; ICD-O-3 histology 9650-9667 (nodal and extranodal)) cdc-uscs 2022 Male All ages 4,879 — observed USCS "Hodgkin Lymphoma" (ICD-10 C81; ICD-O-3 histology 9650-9667 (nodal and extranodal)) cdc-uscs 2021 All All ages 8,673 — observed USCS "Hodgkin Lymphoma" (ICD-10 C81; ICD-O-3 histology 9650-9667 (nodal and extranodal)) cdc-uscs 2021 Female All ages 3,901 — observed USCS "Hodgkin Lymphoma" (ICD-10 C81; ICD-O-3 histology 9650-9667 (nodal and extranodal)) cdc-uscs 2021 Male All ages 4,772 — observed USCS "Hodgkin Lymphoma" (ICD-10 C81; ICD-O-3 histology 9650-9667 (nodal and extranodal)) cdc-uscs 2020 All All ages 8,417 — observed USCS "Hodgkin Lymphoma" (ICD-10 C81; ICD-O-3 histology 9650-9667 (nodal and extranodal)) cdc-uscs 2020 Female All ages 3,768 — observed USCS "Hodgkin Lymphoma" (ICD-10 C81; ICD-O-3 histology 9650-9667 (nodal and extranodal)) cdc-uscs 2020 Male All ages 4,649 — observed USCS "Hodgkin Lymphoma" (ICD-10 C81; ICD-O-3 histology 9650-9667 (nodal and extranodal)) cdc-uscs
Showing the 12 most recent rows of 75; every year is plotted above and available via the API .
Data updated 22 days ago · Source updated USCS 1999-2023 ASCII package, Nov 2025 submission (last-modified Thu, 04 Jun 2026 20:40:00 GMT; sha256 291765c997e5)
All · cdc-uscs — 2006: 1,327 All · cdc-uscs — 2007: 1,271 All · cdc-uscs — 2008: 1,171 All · cdc-uscs — 2009: 1,250 All · cdc-uscs — 2010: 1,231 All · cdc-uscs — 2011: 1,168 All · cdc-uscs — 2012: 1,130 All · cdc-uscs — 2013: 1,090 All · cdc-uscs — 2014: 1,077 All · cdc-uscs — 2015: 1,120 All · cdc-uscs — 2016: 1,000 All · cdc-uscs — 2017: 1,009 All · cdc-uscs — 2018: 1,038 All · cdc-uscs — 2019: 943 All · cdc-uscs — 2020: 1,011 All · cdc-uscs — 2021: 1,003 All · cdc-uscs — 2022: 1,056 All · cdc-uscs — 2023: 1,021 All · cdc-uscs — 2024: 909 All · cdc-wonder — 2018: 1,038 All · cdc-wonder — 2019: 943 All · cdc-wonder — 2020: 1,011 All · cdc-wonder — 2021: 1,003 All · cdc-wonder — 2022: 1,056 All · cdc-wonder — 2023: 1,021 All · cdc-wonder — 2024: 909 Female · cdc-uscs — 1999: 618 Female · cdc-uscs — 2000: 601 Female · cdc-uscs — 2001: 598 Female · cdc-uscs — 2002: 601 Female · cdc-uscs — 2003: 622 Female · cdc-uscs — 2004: 546 Female · cdc-uscs — 2005: 588 Female · cdc-uscs — 2006: 557 Female · cdc-uscs — 2007: 565 Female · cdc-uscs — 2008: 532 Female · cdc-uscs — 2009: 560 Female · cdc-uscs — 2010: 517 Female · cdc-uscs — 2011: 480 Female · cdc-uscs — 2012: 492 Female · cdc-uscs — 2013: 457 Female · cdc-uscs — 2014: 444 Female · cdc-uscs — 2015: 465 Female · cdc-uscs — 2016: 421 Female · cdc-uscs — 2017: 440 Female · cdc-uscs — 2018: 424 Female · cdc-uscs — 2019: 385 Female · cdc-uscs — 2020: 409 Female · cdc-uscs — 2021: 407 Female · cdc-uscs — 2022: 413 Female · cdc-uscs — 2023: 411 Female · cdc-uscs — 2024: 358 Female · cdc-wonder — 2018: 424 Female · cdc-wonder — 2019: 385 Female · cdc-wonder — 2020: 409 Female · cdc-wonder — 2021: 407 Female · cdc-wonder — 2022: 413 Female · cdc-wonder — 2023: 411 Female · cdc-wonder — 2024: 358 Male · cdc-uscs — 1999: 785 Male · cdc-uscs — 2000: 686 Male · cdc-uscs — 2001: 725 Male · cdc-uscs — 2002: 751 Male · cdc-uscs — 2003: 725 Male · cdc-uscs — 2004: 730 Male · cdc-uscs — 2005: 684 Male · cdc-uscs — 2006: 770 Male · cdc-uscs — 2007: 706 Male · cdc-uscs — 2008: 639 Male · cdc-uscs — 2009: 690 Male · cdc-uscs — 2010: 714 Male · cdc-uscs — 2011: 688 Male · cdc-uscs — 2012: 638 Male · cdc-uscs — 2013: 633 Male · cdc-uscs — 2014: 633 Male · cdc-uscs — 2015: 655 Male · cdc-uscs — 2016: 579 Male · cdc-uscs — 2017: 569 Male · cdc-uscs — 2018: 614 Male · cdc-uscs — 2019: 558 Male · cdc-uscs — 2020: 602 Male · cdc-uscs — 2021: 596 Male · cdc-uscs — 2022: 643 Male · cdc-uscs — 2023: 610 Male · cdc-uscs — 2024: 551 Male · cdc-wonder — 2018: 614 Male · cdc-wonder — 2019: 558 Male · cdc-wonder — 2020: 602 Male · cdc-wonder — 2021: 596 Male · cdc-wonder — 2022: 643 Male · cdc-wonder — 2023: 610 Male · cdc-wonder — 2024: 551
cdc-uscs Provenance Source U.S. Cancer Statistics (USCS) — NPCR/SEER incidence and NVSS mortality Dataset U.S. Cancer Statistics — Data Visualizations tool data tables (BYSITE.TXT) Version USCS 1999-2023 ASCII package, Nov 2025 submission (last-modified Thu, 04 Jun 2026 20:40:00 GMT; sha256 291765c997e5) Retrieved Sep 8, 2026 Layer normalized (units and labels harmonized; values unchanged) Evidence registry License US Government work (public domain); citation requested; statistical reporting and analysis only; no linkage for re-identification Run ING-CDCUSCS-20260908-000001 Open at source Observed 99 observations from 2 sources · observations differ by dataset and year: hover a row badge for its dataset and version. Year Sex Age group Value (count) 95% CI Type Site definition Source 2024 All All ages 909 — observed C81 cdc-wonder 2024 All All ages 909 — observed USCS "Hodgkin Lymphoma" (ICD-10 C81; ICD-O-3 histology 9650-9667 (nodal and extranodal)) cdc-uscs 2024 Female All ages 358 — observed C81 cdc-wonder 2024 Female All ages 358 — observed USCS "Hodgkin Lymphoma" (ICD-10 C81; ICD-O-3 histology 9650-9667 (nodal and extranodal)) cdc-uscs 2024 Male All ages 551 — observed USCS "Hodgkin Lymphoma" (ICD-10 C81; ICD-O-3 histology 9650-9667 (nodal and extranodal)) cdc-uscs 2024 Male All ages 551 — observed C81 cdc-wonder 2023 All All ages 1,021 — observed C81 cdc-wonder 2023 All All ages 1,021 — observed USCS "Hodgkin Lymphoma" (ICD-10 C81; ICD-O-3 histology 9650-9667 (nodal and extranodal)) cdc-uscs 2023 Female All ages 411 — observed C81 cdc-wonder 2023 Female All ages 411 — observed USCS "Hodgkin Lymphoma" (ICD-10 C81; ICD-O-3 histology 9650-9667 (nodal and extranodal)) cdc-uscs 2023 Male All ages 610 — observed C81 cdc-wonder 2023 Male All ages 610 — observed USCS "Hodgkin Lymphoma" (ICD-10 C81; ICD-O-3 histology 9650-9667 (nodal and extranodal)) cdc-uscs
Showing the 12 most recent rows of 99; every year is plotted above and available via the API .
Data updated 21 days ago · Source updated USCS 1999-2023 ASCII package, Nov 2025 submission (last-modified Thu, 04 Jun 2026 20:40:00 GMT; sha256 291765c997e5)
Female · cdc-wonder — 2018: 0.3 Female · cdc-wonder — 2019: 0.2 Female · cdc-wonder — 2020: 0.2 Female · cdc-wonder — 2021: 0.2 Female · cdc-wonder — 2022: 0.2 Female · cdc-wonder — 2023: 0.2 Female · cdc-wonder — 2024: 0.2 Male · cdc-wonder — 2018: 0.4 Male · cdc-wonder — 2019: 0.3 Male · cdc-wonder — 2020: 0.4 Male · cdc-wonder — 2021: 0.4 Male · cdc-wonder — 2022: 0.4 Male · cdc-wonder — 2023: 0.4 Male · cdc-wonder — 2024: 0.3
cdc-wonder Provenance Source CDC WONDER — Underlying Cause of Death (US mortality by ICD-10 site) Dataset CDC WONDER Underlying Cause of Death, 2018-2024, Single Race Version D158 vintage 2024 Retrieved Sep 8, 2026 Layer normalized (units and labels harmonized; values unchanged) Evidence registry License US Government work (public domain) subject to CDC WONDER data use restrictions (statistical reporting only; counts ≤ 9 must not be published; no re-identification) Run ING-CDCWONDER-20260908-000001 Open at source Observed 21 observations · observations differ by dataset and year: hover a row badge for its dataset and version. Year Sex Age group Value (per 100,000) 95% CI Type Site definition Source 2024 All All ages 0.3 0.2–0.3 observed C81 cdc-wonder 2024 Female All ages 0.2 0.2–0.2 observed C81 cdc-wonder 2024 Male All ages 0.3 0.3–0.4 observed C81 cdc-wonder 2023 All All ages 0.3 0.3–0.3 observed C81 cdc-wonder 2023 Female All ages 0.2 0.2–0.3 observed C81 cdc-wonder 2023 Male All ages 0.4 0.3–0.4 observed C81 cdc-wonder 2022 All All ages 0.3 0.3–0.3 observed C81 cdc-wonder 2022 Female All ages 0.2 0.2–0.3 observed C81 cdc-wonder 2022 Male All ages 0.4 0.4–0.4 observed C81 cdc-wonder 2021 All All ages 0.3 0.3–0.3 observed C81 cdc-wonder 2021 Female All ages 0.2 0.2–0.3 observed C81 cdc-wonder 2021 Male All ages 0.4 0.3–0.4 observed C81 cdc-wonder
Showing the 12 most recent rows of 21; every year is plotted above and available via the API .
Data updated 21 days ago · Source updated D158 vintage 2024